Effects of rivastigmine treatment on the neuropsychiatric and behavioral disturbances of nursing home residents with moderate to severe probable Alzheimer's disease: A 26-week, multicenter, open-label study-Reference-Cited by-同舟云学术

Effects of rivastigmine treatment on the neuropsychiatric and behavioral disturbances of nursing home residents with moderate to severe probable Alzheimer's disease: A 26-week, multicenter, open-label study

Published:2005-09 Issue:3 Volume:3 Page:137-148
ISSN:1543-5946
Container-title:The American Journal of Geriatric Pharmacotherapy
language:en
Short-container-title:The American Journal of Geriatric Pharmacotherapy

Author:

Cummings Jeffrey L.,Koumaras Barbara,Chen Michael,Mirski Dario

Publisher

Elsevier BV

Subject

Pharmacology (medical),Geriatrics and Gerontology

Reference49 articles.

1. Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank;Barker;Alzheimer Dis Assoc Disord,2002

2. Neuropsychiatry of Alzheimer's Disease and Related Disorders;Cummings,2003

3. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: Results from the cardiovascular health study;Lyketsos;JAMA,2002

4. Mental and behavioral disturbances in dementia: Findings from the Cache County Study on Memory in Aging;Lyketsos;Am J Psychiatry,2000

5. The spectrum of behavioral changes in Alzheimer's disease;Mega;Neurology,1996

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-dementia drugs: what is the evidence in advanced stages?;Porto Biomedical Journal;2024-03

2. Antidementia Medication Use in Nursing Home Residents;Journal of Geriatric Psychiatry and Neurology;2023-09-16

3. A Mobile Application to Assist Alzheimer’s Caregivers During COVID-19 Pandemic: Development and Evaluation;Journal of Caring Sciences;2023-05-20

4. Neuropharmacology of Dementias;NeuroPsychopharmacotherapy;2022

5. Neuroinflammation Modulation via α7 Nicotinic Acetylcholine Receptor and Its Chaperone, RIC-3;Molecules;2021-10-11